sentences:  The combination drug was approved for use in the United States in February 2017, where it is sold under the brand name Qtern.In May 2019, the fixed-dose combination of dapagliflozin, saxagliptin, and metformin hydrochloride as extended-release tablets was approved in the United States to improve glycemic control in adults with type 2 diabetes when used in combination with diet and exercise.The FDA granted the approval of Qternmet XR to AstraZeneca.